Jinwon Life Sciences Subsidiary VGXI Participates in JP Morgan Healthcare Conference
[Asia Economy Reporter Jang Hyowon] GeneOne Life Science announced on the 5th that its subsidiary VGXI has been officially invited to participate in the 40th J.P. Morgan Healthcare Conference.
The 40th J.P. Morgan Healthcare Conference will be held from the 10th to the 13th in San Francisco, USA, and will be conducted online due to the COVID-19 situation. This event is the world's largest pharmaceutical/biotech event where healthcare companies and institutional investors from around the globe gather. Hosted by the global investment bank J.P. Morgan Chase, it attracts significant attention as it provides opportunities to meet investors worldwide and explore new market entry possibilities.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Lee Jun-seok: "People Power Party's Armchair Politics... Reform Party Will Keep Running Until the End"
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
CEO Park Younggeun stated, “As the gene therapy and mRNA vaccine markets rapidly expand, the global demand for pharmaceutical production of plasmid DNA and mRNA bulk substances is surging. Starting from the second quarter, we plan to conduct sales activities for the contract manufacturing of our new Plant 1, which will operate at a commercial scale, as well as seek various partnership opportunities for the three COVID-19 pharmaceuticals we are developing.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
